Publications by authors named "Christopher Letson"

Claim this Profile
A
A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies.
Fan He, Shuyang Lin, Bei Gao, Varun Ramesh, Alexander B Kim, Christopher T Letson

Cell Commun Signal· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53-mutated myeloid malignancies.
Traci L Kruer, Ariel Quintana, Hannah Newman, Meghan Ferrall-Fairbanks, Ling Zhang, Christopher Letson

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
Tim Kong, Angelo B A Laranjeira, Christopher T Letson, LaYow Yu, Shuyang Lin

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.
Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, Hannah Newman, Ariel Quintana, Christopher T Letson

Cancer Discov· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RSK1 dependency in FLT3-ITD acute myeloid leukemia.
Tim Kong, Angelo B A Laranjeira, Christopher T Letson, LaYow Yu, Fan He

Blood Cancer J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML.
Christopher T Letson, Maria E Balasis, Hannah Newman, Moritz Binder, Alexis Vedder

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, Hannah Newman, Virginia Volpe, Christopher Letson

Blood Cancer Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia.
Anthony M Hunter, Hannah Newman, Amy E Dezern, David P Steensma, Sandrine Niyongere, Christopher Letson

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.
Mrinal M Patnaik, David A Sallman, Abhishek A Mangaonkar, Rachel Heuer, Jeffery Hirvela, Christopher Letson

Blood· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-canonical transcriptional consequences of BET inhibition in cancer.
Christopher Letson, Eric Padron

Pharmacol Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of on Engraftment of Patient-derived Chronic-Myelomonocytic Leukemia Cells in NSGS Mice.
Alexis R Vedder, Emily L Miedel, Natalie H Ragland, Maria E Balasis, Christopher T Letson

Comp Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulating Notch counteracts Kras-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.
Guangyao Kong, Xiaona You, Zhi Wen, Yuan-I Chang, Shuiming Qian, Christopher Letson

Leukemia· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
Akihide Yoshimi, Maria E Balasis, Alexis Vedder, Kira Feldman, Yan Ma, Christopher Letson

Blood· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.
Cornelis Blauwendraat, Mike A Nalls, Monica Federoff, Olga Pletnikova, Jinhui Ding, Christopher Letson

Mov Disord· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.
Joshua T Geiger, Jinhui Ding, Barbara Crain, Olga Pletnikova, Christopher Letson

Neurobiol Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Mike A Nalls, Cory Y McLean, Jacqueline Rick, Shirley Eberly, Samantha J Hutten, Christopher Letson

Lancet Neurol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Mike A Nalls, Nathan Pankratz, Christina M Lill, Chuong B Do, Dena G Hernandez, Christopher Letson

Nat Genet· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Parkinson's disease risk loci in Greece.
Eleanna Kara, Georgia Xiromerisiou, Cleanthe Spanaki, Maria Bozi, Georgios Koutsis, Christopher Letson

Neurobiol Aging· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA-34a promotes DNA damage and mitotic catastrophe.
Alexander V Kofman, Jungeun Kim, So Yeon Park, Evan Dupart, Christopher Letson

Cell Cycle· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.
Alexander V Kofman, Christopher Letson, Evan Dupart, Yongde Bao, William W Newcomb

Med Hypotheses· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis